Loading...
•
Sep 30, 2020
Biolase Q3 2020 Earnings Report
Revenue increased sequentially driven by the reopening of dental practices and a product portfolio that reduces the risk of infectious pathogens.
Key Takeaways
BIOLASE reported a strong sequential revenue growth in Q3 2020. Total revenue more than doubled sequentially, while U.S. laser revenue increased 16% year over year. The company significantly strengthened its balance sheet with an $18.0 million equity raise.
U.S. laser revenue increased 16% year over year
U.S. consumables and other revenue increased 25% year over year
New customers represented over 90% of U.S. laser sales in the quarter
Total revenue more than doubled sequentially, while down 24% year over year
Biolase
Biolase
Biolase Revenue by Segment
Biolase Revenue by Geographic Location
Revenue by Segment
US Laser Revenue
CapyFin.comRevenue by Geographic Location
Outside U.S. Revenue
CapyFin.com Forward Guidance
BIOLASE did not provide forward guidance in its Q3 2020 earnings report.